1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Generic and Biosimilar Pharmaceuticals Market Size by Type: 2016 VS 2021 VS 2027 1.2.2 Monoclonal Antibodies 1.2.3 Interferon 1.2.4 Erythropoietin 1.2.5 Insulin 1.2.6 Vaccines 1.2.7 Other 1.3 Market by Application 1.3.1 Global Generic and Biosimilar Pharmaceuticals Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Tumor 1.3.3 Diabetes 1.3.4 Cardiovascular 1.3.5 Hemophilia 1.3.6 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trend 2.1 Global Generic and Biosimilar Pharmaceuticals Market Perspective (2016-2027) 2.2 Global Generic and Biosimilar Pharmaceuticals Growth Trends by Regions 2.2.1 Generic and Biosimilar Pharmaceuticals Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Generic and Biosimilar Pharmaceuticals Historic Market Size by Regions (2016-2021) 2.2.3 Generic and Biosimilar Pharmaceuticals Forecasted Market Size by Regions (2022-2027) 2.3 Industry Trends and Growth Strategy 2.3.1 Generic and Biosimilar Pharmaceuticals Industry Trends 2.3.2 Generic and Biosimilar Pharmaceuticals Market Drivers 2.3.3 Generic and Biosimilar Pharmaceuticals Market Challenges 2.3.4 Generic and Biosimilar Pharmaceuticals Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Generic and Biosimilar Pharmaceuticals Players by Market Size 3.1.1 Players Covered: Ranking by Generic and Biosimilar Pharmaceuticals Revenue 3.1.2 Global Top Generic and Biosimilar Pharmaceuticals Players by Revenue (2016-2021) 3.1.3 Global Generic and Biosimilar Pharmaceuticals Revenue Market Share by Players (2016-2021) 3.1.4 Global Generic and Biosimilar Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Generic and Biosimilar Pharmaceuticals Market Concentration Ratio 3.2.1 Global Generic and Biosimilar Pharmaceuticals Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 5 and Top 10 Players by Generic and Biosimilar Pharmaceuticals Revenue in 2020 3.3 Generic and Biosimilar Pharmaceuticals Key Players Head office and Area Served 3.4 Key Players Generic and Biosimilar Pharmaceuticals Product Solution and Service 3.5 Date of Enter into Generic and Biosimilar Pharmaceuticals Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Global Generic and Biosimilar Pharmaceuticals Breakdown Data by Type (2016-2027) 4.1 Global Generic and Biosimilar Pharmaceuticals Historic Market Size by Type (2016-2021) 4.2 Global Generic and Biosimilar Pharmaceuticals Forecasted Market Size by Type (2022-2027) 5 Global Generic and Biosimilar Pharmaceuticals Breakdown Data by Application (2016-2027) 5.1 Global Generic and Biosimilar Pharmaceuticals Historic Market Size by Application (2016-2021) 5.2 Generic and Biosimilar Pharmaceuticals Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 6.2 Key Generic and Biosimilar Pharmaceuticals Players Market Share in North America (2020-2021) 6.3 North America Generic and Biosimilar Pharmaceuticals Market Size by Country 6.3.1 North America Generic and Biosimilar Pharmaceuticals Market Size by Country (2016-2021) 6.3.2 North America Generic and Biosimilar Pharmaceuticals Market Size Forecast by Country (2022-2027) 6.4 U.S. Market Size Analysis 6.4.1 U.S. Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 6.4.2 U.S. Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 6.4.3 U.S. Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 6.5 Canada Market Size Analysis 6.5.1 Canada Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 6.5.2 Canada Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 6.5.3 Canada Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 7 Europe 7.1 Europe Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 7.2 Key Generic and Biosimilar Pharmaceuticals Players Market Share in Europe (2020-2021) 7.3 Europe Generic and Biosimilar Pharmaceuticals Market Size by Country 7.3.1 Europe Generic and Biosimilar Pharmaceuticals Market Size by Country (2016-2021) 7.3.2 Europe Generic and Biosimilar Pharmaceuticals Market Size Forecast by Country (2022-2027) 7.4 Germany Market Size Analysis 7.4.1 Germany Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 7.4.2 Germany Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 7.4.3 Germany Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 7.5 France Market Size Analysis 7.5.1 France Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 7.5.2 France Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 7.5.3 France Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 7.6 U.K. Market Size Analysis 7.6.1 U.K. Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 7.6.2 U.K. Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 7.6.3 U.K. Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 7.7 Italy Market Size Analysis 7.7.1 Italy Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 7.7.2 Italy Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 7.7.3 Italy Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 7.8 Russia Market Size Analysis 7.8.1 Russia Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 7.8.2 Russia Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 7.8.3 Russia Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 8 Asia-Pacific 8.1 Asia-Pacific Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 8.2 Key Generic and Biosimilar Pharmaceuticals Players Market Share in Asia-Pacific (2020-2021) 8.3 Asia-Pacific Generic and Biosimilar Pharmaceuticals Market Size by Region 8.3.1 Asia-Pacific Generic and Biosimilar Pharmaceuticals Market Size by Region (2016-2021) 8.3.2 Asia-Pacific Generic and Biosimilar Pharmaceuticals Market Size Forecast by Region (2022-2027) 8.4 China Market Size Analysis 8.4.1 China Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 8.4.2 China Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 8.4.3 China Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 8.5 Japan Market Size Analysis 8.5.1 Japan Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 8.5.2 Japan Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 8.5.3 Japan Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 8.6 South Korea Market Size Analysis 8.6.1 South Korea Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 8.6.2 South Korea Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 8.6.3 South Korea Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 8.7 India Market Size Analysis 8.7.1 India Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 8.7.2 India Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 8.7.3 India Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 8.8 Australia Market Size Analysis 8.8.1 Australia Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 8.8.2 Australia Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 8.8.3 Australia Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 8.9 Taiwan Market Size Analysis 8.9.1 Taiwan Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 8.9.2 Taiwan Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 8.9.3 Taiwan Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 8.10 Indonesia Market Size Analysis 8.10.1 Indonesia Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 8.10.2 Indonesia Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 8.10.3 Indonesia Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 8.11 Thailand Market Size Analysis 8.11.1 Thailand Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 8.11.2 Thailand Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 8.11.3 Thailand Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 8.12 Malaysia Market Size Analysis 8.12.1 Malaysia Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 8.12.2 Malaysia Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 8.12.3 Malaysia Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 8.13 Philippines Market Size Analysis 8.13.1 Philippines Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 8.13.2 Philippines Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 8.13.3 Philippines Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 8.14 Vietnam Market Size Analysis 8.14.1 Vietnam Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 8.14.2 Vietnam Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 8.14.3 Vietnam Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 9 Latin America 9.1 Latin America Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 9.2 Key Generic and Biosimilar Pharmaceuticals Players Market Share in Latin America (2020-2021) 9.3 Latin America Generic and Biosimilar Pharmaceuticals Market Size by Country 9.3.1 Latin America Generic and Biosimilar Pharmaceuticals Market Size by Country (2016-2021) 9.3.2 Latin America Generic and Biosimilar Pharmaceuticals Market Size Forecast by Country (2022-2027) 9.4 Mexico Market Size Analysis 9.4.1 Mexico Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 9.4.2 Mexico Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 9.4.3 Mexico Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 9.5 Brazil Market Size Analysis 9.5.1 Brazil Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 9.5.2 Brazil Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 9.5.3 Brazil Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 9.6 Argentina Market Size Analysis 9.6.1 Argentina Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 9.6.2 Argentina Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 9.6.3 Argentina Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 10 Middle East & Africa 10.1 Middle East & Africa Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 10.2 Key Generic and Biosimilar Pharmaceuticals Players Market Share in Middle East & Africa (2020-2021) 10.3 Middle East & Africa Generic and Biosimilar Pharmaceuticals Market Size by Country 10.3.1 Middle East & Africa Generic and Biosimilar Pharmaceuticals Market Size by Country (2016-2021) 10.3.2 Middle East & Africa Generic and Biosimilar Pharmaceuticals Market Size Forecast by Country (2022-2027) 10.4 Turkey Market Size Analysis 10.4.1 Turkey Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 10.4.2 Turkey Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 10.4.3 Turkey Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 10.5 Saudi Arabia Market Size Analysis 10.5.1 Saudi Arabia Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 10.5.2 Saudi Arabia Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 10.5.3 Saudi Arabia Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 10.6 UAE Market Size Analysis 10.6.1 UAE Generic and Biosimilar Pharmaceuticals Market Size (2016-2027) 10.6.2 UAE Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2027) 10.6.3 UAE Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2027) 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview and Its Total Revenue 11.1.3 Roche Generic and Biosimilar Pharmaceuticals Introduction 11.1.4 Roche Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.1.5 Roche Recent Development 11.2 Amgen 11.2.1 Amgen Company Details 11.2.2 Amgen Business Overview and Its Total Revenue 11.2.3 Amgen Generic and Biosimilar Pharmaceuticals Introduction 11.2.4 Amgen Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.2.5 Amgen Recent Development 11.3 AbbVie 11.3.1 AbbVie Company Details 11.3.2 AbbVie Business Overview and Its Total Revenue 11.3.3 AbbVie Generic and Biosimilar Pharmaceuticals Introduction 11.3.4 AbbVie Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.3.5 AbbVie Recent Development 11.4 Sanofi-Aventis 11.4.1 Sanofi-Aventis Company Details 11.4.2 Sanofi-Aventis Business Overview and Its Total Revenue 11.4.3 Sanofi-Aventis Generic and Biosimilar Pharmaceuticals Introduction 11.4.4 Sanofi-Aventis Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.4.5 Sanofi-Aventis Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview and Its Total Revenue 11.5.3 Johnson & Johnson Generic and Biosimilar Pharmaceuticals Introduction 11.5.4 Johnson & Johnson Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.5.5 Johnson & Johnson Recent Development 11.6 Pfizer 11.6.1 Pfizer Company Details 11.6.2 Pfizer Business Overview and Its Total Revenue 11.6.3 Pfizer Generic and Biosimilar Pharmaceuticals Introduction 11.6.4 Pfizer Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.6.5 Pfizer Recent Development 11.7 Novo Nordisk 11.7.1 Novo Nordisk Company Details 11.7.2 Novo Nordisk Business Overview and Its Total Revenue 11.7.3 Novo Nordisk Generic and Biosimilar Pharmaceuticals Introduction 11.7.4 Novo Nordisk Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.7.5 Novo Nordisk Recent Development 11.8 Eli Lilly 11.8.1 Eli Lilly Company Details 11.8.2 Eli Lilly Business Overview and Its Total Revenue 11.8.3 Eli Lilly Generic and Biosimilar Pharmaceuticals Introduction 11.8.4 Eli Lilly Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.8.5 Eli Lilly Recent Development 11.9 Novartis 11.9.1 Novartis Company Details 11.9.2 Novartis Business Overview and Its Total Revenue 11.9.3 Novartis Generic and Biosimilar Pharmaceuticals Introduction 11.9.4 Novartis Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.9.5 Novartis Recent Development 11.10 Merck 11.10.1 Merck Company Details 11.10.2 Merck Business Overview and Its Total Revenue 11.10.3 Merck Generic and Biosimilar Pharmaceuticals Introduction 11.10.4 Merck Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.10.5 Merck Recent Development 11.11 3sbio 11.11.1 3sbio Company Details 11.11.2 3sbio Business Overview and Its Total Revenue 11.11.3 3sbio Generic and Biosimilar Pharmaceuticals Introduction 11.11.4 3sbio Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.11.5 3sbio Recent Development 11.12 Changchun High Tech 11.12.1 Changchun High Tech Company Details 11.12.2 Changchun High Tech Business Overview and Its Total Revenue 11.12.3 Changchun High Tech Generic and Biosimilar Pharmaceuticals Introduction 11.12.4 Changchun High Tech Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.12.5 Changchun High Tech Recent Development 11.13 CP Guojian 11.13.1 CP Guojian Company Details 11.13.2 CP Guojian Business Overview and Its Total Revenue 11.13.3 CP Guojian Generic and Biosimilar Pharmaceuticals Introduction 11.13.4 CP Guojian Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.13.5 CP Guojian Recent Development 11.14 Biotech 11.14.1 Biotech Company Details 11.14.2 Biotech Business Overview and Its Total Revenue 11.14.3 Biotech Generic and Biosimilar Pharmaceuticals Introduction 11.14.4 Biotech Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.14.5 Biotech Recent Development 11.15 Gelgen 11.15.1 Gelgen Company Details 11.15.2 Gelgen Business Overview and Its Total Revenue 11.15.3 Gelgen Generic and Biosimilar Pharmaceuticals Introduction 11.15.4 Gelgen Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.15.5 Gelgen Recent Development 11.16 Innovent 11.16.1 Innovent Company Details 11.16.2 Innovent Business Overview and Its Total Revenue 11.16.3 Innovent Generic and Biosimilar Pharmaceuticals Introduction 11.16.4 Innovent Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.16.5 Innovent Recent Development 11.17 Dong Bao 11.17.1 Dong Bao Company Details 11.17.2 Dong Bao Business Overview and Its Total Revenue 11.17.3 Dong Bao Generic and Biosimilar Pharmaceuticals Introduction 11.17.4 Dong Bao Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.17.5 Dong Bao Recent Development 11.18 Ganlee 11.18.1 Ganlee Company Details 11.18.2 Ganlee Business Overview and Its Total Revenue 11.18.3 Ganlee Generic and Biosimilar Pharmaceuticals Introduction 11.18.4 Ganlee Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) 11.18.5 Ganlee Recent Development 12 Analyst's Viewpoints/Conclusion 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer

List of Tables Table 1. Global Generic and Biosimilar Pharmaceuticals Market Size Growth Rate by Type (US$ Million): 2016 VS 2021 VS 2027 Table 2. Key Players of Monoclonal Antibodies Table 3. Key Players of Interferon Table 4. Key Players of Erythropoietin Table 5. Key Players of Insulin Table 6. Key Players of Vaccines Table 7. Key Players of Other Table 8. Global Generic and Biosimilar Pharmaceuticals Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Generic and Biosimilar Pharmaceuticals Market Size by Region (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Generic and Biosimilar Pharmaceuticals Market Size by Regions (2016-2021) & (US$ Million) Table 11. Global Generic and Biosimilar Pharmaceuticals Market Share by Regions (2016-2021) Table 12. Global Generic and Biosimilar Pharmaceuticals Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 13. Global Generic and Biosimilar Pharmaceuticals Market Share by Regions (2022-2027) Table 14. Generic and Biosimilar Pharmaceuticals Market Trends Table 15. Generic and Biosimilar Pharmaceuticals Market Drivers Table 16. Generic and Biosimilar Pharmaceuticals Market Challenges Table 17. Generic and Biosimilar Pharmaceuticals Market Restraints Table 18. Ranking of Global Top Generic and Biosimilar Pharmaceuticals Manufacturers by Revenue (US$ Million) in 2020 Table 19. Global Generic and Biosimilar Pharmaceuticals Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Generic and Biosimilar Pharmaceuticals Market Share by Players (2016-2021) Table 21. Global Top Generic and Biosimilar Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic and Biosimilar Pharmaceuticals as of 2020) Table 22. Global 5 Largest Players Market Share by Generic and Biosimilar Pharmaceuticals Revenue (CR5 and HHI) (2016-2021) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Generic and Biosimilar Pharmaceuticals Product Solution and Service Table 25. Date of Enter into Generic and Biosimilar Pharmaceuticals Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Generic and Biosimilar Pharmaceuticals Market Size by Type (2016-2021) & (US$ Million) Table 28. Global Generic and Biosimilar Pharmaceuticals Revenue Market Share by Type (2016-2021) Table 29. Global Generic and Biosimilar Pharmaceuticals Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 30. Global Generic and Biosimilar Pharmaceuticals Revenue Market Share by Type (2022-2027) Table 31. Global Generic and Biosimilar Pharmaceuticals Market Size by Application (2016-2021) & (US$ Million) Table 32. Global Generic and Biosimilar Pharmaceuticals Revenue Market Share by Application (2016-2021) Table 33. Global Generic and Biosimilar Pharmaceuticals Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 34. Global Generic and Biosimilar Pharmaceuticals Revenue Market Share by Application (2022-2027) Table 35. Key Players Generic and Biosimilar Pharmaceuticals Revenue in North America (2020-2021) (US$ Million) Table 36. North America Generic and Biosimilar Pharmaceuticals Market Size by Countries (2016-2021) & (US$ Million) Table 37. North America Generic and Biosimilar Pharmaceuticals Market Size Share by Countries (2016-2021) Table 38. North America Generic and Biosimilar Pharmaceuticals Market Size by Countries (2022-2027) & (US$ Million) Table 39. North America Generic and Biosimilar Pharmaceuticals Market Size Share by Countries (2022-2027) Table 40. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.S., Breakdown by Type (2016-2021) Table 41. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.S., Breakdown by Type (2022-2027) Table 42. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.S., Breakdown by Application (2016-2021) Table 43. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.S., Breakdown by Application (2022-2027) Table 44. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Canada, Breakdown by Type (2016-2021) Table 45. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Canada, Breakdown by Type (2022-2027) Table 46. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Canada, Breakdown by Application (2016-2021) Table 47. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Canada, Breakdown by Application (2022-2027) Table 48. Key Players Generic and Biosimilar Pharmaceuticals Revenue in Europe (2020-2021) (US$ Million) Table 49. Europe Generic and Biosimilar Pharmaceuticals Market Size by Countries (2016-2021) & (US$ Million) Table 50. Europe Generic and Biosimilar Pharmaceuticals Market Size Share by Countries (2016-2021) Table 51. Europe Generic and Biosimilar Pharmaceuticals Market Size by Countries (2022-2027) & (US$ Million) Table 52. Europe Generic and Biosimilar Pharmaceuticals Market Size Share by Countries (2022-2027) Table 53. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Germany, Breakdown by Type (2016-2021) Table 54. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Germany, Breakdown by Type (2022-2027) Table 55. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Germany, Breakdown by Application (2016-2021) Table 56. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Germany, Breakdown by Application (2022-2027) Table 57. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in France, Breakdown by Type (2016-2021) Table 58. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in France, Breakdown by Type (2022-2027) Table 59. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in France, Breakdown by Application (2016-2021) Table 60. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in France, Breakdown by Application (2022-2027) Table 61. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.K., Breakdown by Type (2016-2021) Table 62. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.K., Breakdown by Type (2022-2027) Table 63. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.K., Breakdown by Application (2016-2021) Table 64. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in U.K., Breakdown by Application (2022-2027) Table 65. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Italy, Breakdown by Type (2016-2021) Table 66. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Italy, Breakdown by Type (2022-2027) Table 67. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Italy, Breakdown by Application (2016-2021) Table 68. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Italy, Breakdown by Application (2022-2027) Table 69. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Russia, Breakdown by Type (2016-2021) Table 70. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Russia, Breakdown by Type (2022-2027) Table 71. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Russia, Breakdown by Application (2016-2021) Table 72. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Russia, Breakdown by Application (2022-2027) Table 73. Key Players Generic and Biosimilar Pharmaceuticals Revenue in Asia-Pacific (2020-2021) (US$ Million) Table 74. Asia-Pacific Generic and Biosimilar Pharmaceuticals Market Size by Regions (2016-2021) & (US$ Million) Table 75. Asia-Pacific Generic and Biosimilar Pharmaceuticals Market Size by Regions (2022-2027) & (US$ Million) Table 76. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in China, Breakdown by Type (2016-2021) Table 77. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in China, Breakdown by Type (2022-2027) Table 78. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in China, Breakdown by Application (2016-2021) Table 79. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in China, Breakdown by Application (2022-2027) Table 80. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Japan, Breakdown by Type (2016-2021) Table 81. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Japan, Breakdown by Type (2022-2027) Table 82. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Japan, Breakdown by Application (2016-2021) Table 83. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Japan, Breakdown by Application (2022-2027) Table 84. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in South Korea, Breakdown by Type (2016-2021) Table 85. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in South Korea, Breakdown by Type (2022-2027) Table 86. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in South Korea, Breakdown by Application (2016-2021) Table 87. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in South Korea, Breakdown by Application (2022-2027) Table 88. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in India, Breakdown by Type (2016-2021) Table 89. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in India, Breakdown by Type (2022-2027) Table 90. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in India, Breakdown by Application (2016-2021) Table 91. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in India, Breakdown by Application (2022-2027) Table 92. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Australia, Breakdown by Type (2016-2021) Table 93. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Australia, Breakdown by Type (2022-2027) Table 94. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Australia, Breakdown by Application (2016-2021) Table 95. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Australia, Breakdown by Application (2022-2027) Table 96. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Taiwan, Breakdown by Type (2016-2021) Table 97. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Taiwan, Breakdown by Type (2022-2027) Table 98. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Taiwan, Breakdown by Application (2016-2021) Table 99. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Taiwan, Breakdown by Application (2022-2027) Table 100. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Indonesia, Breakdown by Type (2016-2021) Table 101. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Indonesia, Breakdown by Type (2022-2027) Table 102. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Indonesia, Breakdown by Application (2016-2021) Table 103. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Indonesia, Breakdown by Application (2022-2027) Table 104. Key Players Generic and Biosimilar Pharmaceuticals Revenue in Latin America (2020-2021) (US$ Million) Table 105. Latin America Generic and Biosimilar Pharmaceuticals Market Size by Countries (2016-2021) & (US$ Million) Table 106. Latin America Generic and Biosimilar Pharmaceuticals Market Size by Countries (2022-2027) & (US$ Million) Table 107. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Mexico, Breakdown by Type (2016-2021) Table 108. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Mexico, Breakdown by Type (2022-2027) Table 109. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Mexico, Breakdown by Application (2016-2021) Table 110. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Mexico, Breakdown by Application (2022-2027) Table 111. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Brazil, Breakdown by Type (2016-2021) Table 112. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Brazil, Breakdown by Type (2022-2027) Table 113. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Brazil, Breakdown by Application (2016-2021) Table 114. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Brazil, Breakdown by Application (2022-2027) Table 115. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Argentina, Breakdown by Type (2016-2021) Table 116. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Argentina, Breakdown by Type (2022-2027) Table 117. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Argentina, Breakdown by Application (2016-2021) Table 118. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Argentina, Breakdown by Application (2022-2027) Table 119. Key Players Generic and Biosimilar Pharmaceuticals Revenue in Middle East & Africa (2020-2021) (US$ Million) Table 120. Middle East & Africa Generic and Biosimilar Pharmaceuticals Market Size by Countries (2016-2021) & (US$ Million) Table 121. Middle East & Africa Generic and Biosimilar Pharmaceuticals Market Size by Countries (2022-2027) & (US$ Million) Table 122. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Turkey, Breakdown by Type (2016-2021) Table 123. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Turkey, Breakdown by Type (2022-2027) Table 124. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Turkey, Breakdown by Application (2016-2021) Table 125. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Turkey, Breakdown by Application (2022-2027) Table 126. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2016-2021) Table 127. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2022-2027) Table 128. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2016-2021) Table 129. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2022-2027) Table 130. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in UAE, Breakdown by Type (2016-2021) Table 131. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in UAE, Breakdown by Type (2022-2027) Table 132. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in UAE, Breakdown by Application (2016-2021) Table 133. Generic and Biosimilar Pharmaceuticals Market Size (US$ Million) in UAE, Breakdown by Application (2022-2027) Table 134. Roche Company Details Table 135. Roche Business Overview Table 136. Roche Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 137. Roche Generic and Biosimilar Pharmaceuticals Generic and Biosimilar Pharmaceuticals Product Table 138. Roche Recent Development Table 139. Amgen Company Details Table 140. Amgen Business Overview Table 141. Amgen Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 142. Amgen Generic and Biosimilar Pharmaceuticals Product Table 143. Amgen Recent Development Table 144. AbbVie Company Details Table 145. AbbVie Business Overview Table 146. AbbVie Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 147. AbbVie Generic and Biosimilar Pharmaceuticals Product Table 148. AbbVie Recent Development Table 149. Sanofi-Aventis Company Details Table 150. Sanofi-Aventis Business Overview Table 151. Sanofi-Aventis Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 152. Sanofi-Aventis Generic and Biosimilar Pharmaceuticals Product Table 153. Sanofi-Aventis Recent Development Table 154. Johnson & Johnson Company Details Table 155. Johnson & Johnson Business Overview Table 156. Johnson & Johnson Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 157. Johnson & Johnson Generic and Biosimilar Pharmaceuticals Product Table 158. Johnson & Johnson Recent Development Table 159. Pfizer Company Details Table 160. Pfizer Business Overview Table 161. Pfizer Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 162. Pfizer Generic and Biosimilar Pharmaceuticals Product Table 163. Pfizer Recent Development Table 164. Novo Nordisk Company Details Table 165. Novo Nordisk Business Overview Table 166. Novo Nordisk Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 167. Novo Nordisk Generic and Biosimilar Pharmaceuticals Product Table 168. Novo Nordisk Recent Development Table 169. Eli Lilly Company Details Table 170. Eli Lilly Business Overview Table 171. Eli Lilly Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 172. Eli Lilly Generic and Biosimilar Pharmaceuticals Product Table 173. Eli Lilly Recent Development Table 174. Novartis Company Details Table 175. Novartis Business Overview Table 176. Novartis Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 177. Novartis Generic and Biosimilar Pharmaceuticals Product Table 178. Novartis Recent Development Table 179. Merck Company Details Table 180. Merck Business Overview Table 181. Merck Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 182. Merck Generic and Biosimilar Pharmaceuticals Product Table 183. Merck Recent Development Table 184. 3sbio Company Details Table 185. 3sbio Business Overview Table 186. 3sbio Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 187. 3sbio Generic and Biosimilar Pharmaceuticals Product Table 188. 3sbio Recent Development Table 189. Changchun High Tech Company Details Table 190. Changchun High Tech Business Overview Table 191. Changchun High Tech Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 192. Changchun High Tech Generic and Biosimilar Pharmaceuticals Product Table 193. Changchun High Tech Recent Development Table 194. CP Guojian Company Details Table 195. CP Guojian Business Overview Table 196. CP Guojian Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 197. CP Guojian Generic and Biosimilar Pharmaceuticals Product Table 198. CP Guojian Recent Development Table 199. Biotech Company Details Table 200. Biotech Business Overview Table 201. Biotech Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 202. Biotech Generic and Biosimilar Pharmaceuticals Product Table 203. Biotech Recent Development Table 204. Gelgen Company Details Table 205. Gelgen Business Overview Table 206. Gelgen Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 207. Gelgen Generic and Biosimilar Pharmaceuticals Product Table 208. Gelgen Recent Development Table 209. Innovent Company Details Table 210. Innovent Business Overview Table 211. Innovent Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 212. Innovent Generic and Biosimilar Pharmaceuticals Product Table 213. Innovent Recent Development Table 214. Dong Bao Company Details Table 215. Dong Bao Business Overview Table 216. Dong Bao Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 217. Dong Bao Generic and Biosimilar Pharmaceuticals Product Table 218. Dong Bao Recent Development Table 219. Ganlee Company Details Table 220. Ganlee Business Overview Table 221. Ganlee Revenue in Generic and Biosimilar Pharmaceuticals Business (2016-2021) & (US$ Million) Table 222. Ganlee Generic and Biosimilar Pharmaceuticals Product Table 223. Ganlee Recent Development Table 224. Research Programs/Design for This Report Table 225. Key Data Information from Secondary Sources Table 226. Key Data Information from Primary Sources List of Figures Figure 1. Global Generic and Biosimilar Pharmaceuticals Market Share by Type: 2020 & 2027 Figure 2. Monoclonal Antibodies Features Figure 3. Interferon Features Figure 4. Erythropoietin Features Figure 5. Insulin Features Figure 6. Vaccines Features Figure 7. Other Features Figure 8. Global Generic and Biosimilar Pharmaceuticals Market Share by Application: 2020 & 2027 Figure 9. Tumor Case Studies Figure 10. Diabetes Case Studies Figure 11. Cardiovascular Case Studies Figure 12. Hemophilia Case Studies Figure 13. Other Case Studies Figure 14. Generic and Biosimilar Pharmaceuticals Report Years Considered Figure 15. Global Generic and Biosimilar Pharmaceuticals Market Share by Regions: 2016 VS 2021 VS 2027 Figure 16. Global Generic and Biosimilar Pharmaceuticals Market Size YoY Growth 2016-2027 (US$ Million) Figure 17. Global Generic and Biosimilar Pharmaceuticals Market Share by Regions (2022-2027) Figure 18. Global Generic and Biosimilar Pharmaceuticals Market Share by Players in 2020 Figure 19. Global Top Generic and Biosimilar Pharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic and Biosimilar Pharmaceuticals as of 2020) Figure 20. The Top 10 and 5 Players Market Share by Generic and Biosimilar Pharmaceuticals Revenue in 2020 Figure 21. North America Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. U.S. Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Germany Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. France Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. U.K. Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Italy Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Russia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Asia-Pacific Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. China Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Japan Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. South Korea Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. India Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Australia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Taiwan Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Indonesia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Thailand Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Malaysia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Philippines Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Vietnam Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Latin America Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Mexico Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Brazil Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Argentina Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Middle East & Africa Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Turkey Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Saudi Arabia Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. UAE Generic and Biosimilar Pharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

Roche Amgen AbbVie Sanofi-Aventis Johnson & Johnson Pfizer Novo Nordisk Eli Lilly Novartis Merck 3sbio Changchun High Tech CP Guojian Biotech Gelgen Innovent Dong Bao Ganlee